Sort
51,593 grants matching “hepatitis”
Retrovial Infections of the Nervous System in Peru
$555,061Joseph Raymond Zunt · University Of Washington · R01 · FY2009 · NS
Dietary treatment of Glucose Transporter Type 1 Deficiency (G1D)
$554,982Juan M. Pascual · Ut Southwestern Medical Center · R01 · FY2020 · NS
Role of Screening and Early Intervention in Primary Care with Low-Dose Pioglitazone for Patients with T2DM and NASH
$554,963Kenneth Cusi · University Of Florida · R01 · FY2022 · DK
Cytapheresis Of Volunteer Donors (MRI 2003-054)
$554,949Josephine Egan · National Institute On Aging · ZID · FY2011 · AG
WOMEN DRUG USERS, THEIR MALE PARTNERS AND HIV RISK
$554,924National Development &Res Institutes · R01 · FY2003 · DA
Roles of SLC26 Transporters in Urinary Oxalate Excretion and Kidney Disease
$554,868Peter S Aronson · Yale University · R01 · FY2021 · DK
Roles of SLC26 Transporters in Urinary Oxalate Excretion and Kidney Disease
$554,868Peter S Aronson · Yale University · R01 · FY2018 · DK
Roles of SLC26 Transporters in Urinary Oxalate Excretion and Kidney Disease
$554,867Peter S Aronson · Yale University · R01 · FY2022 · DK
Roles of SLC26 Transporters in Urinary Oxalate Excretion and Kidney Disease
$554,867Peter S Aronson · Yale University · R01 · FY2020 · DK
Roles of SLC26 Transporters in Urinary Oxalate Excretion and Kidney Disease
$554,867Peter S Aronson · Yale University · R01 · FY2019 · DK
HCC Risk Stratification in MAFLD Cirrhosis
$554,835Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2025 · CA
The application of human collagen kinetic biomarkers to anti-fibrotic drug develo
$554,823Scott M Turner · Kinemed, Inc. · R44 · FY2009 · CA
Mechanisms of Innate and Adaptive Immune Responses to AAV-FVIII Gene Transfer
$554,819Roland W. Herzog · Indiana University Indianapolis · P01 · FY2022 · HL
Multi-Center Study of the Treatment of T2DM in Youth
$554,784Sonia Caprio · Yale University · U01 · FY2007 · DK
Understanding B cell memory in response to diverse virus infections
$554,702Michel C Nussenzweig · Rockefeller University · U19 · FY2021 · AI
Understanding B cell memory in response to diverse virus infections
$554,701Michel C Nussenzweig · Rockefeller University · U19 · FY2020 · AI
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care
$554,667Pedro Mateu-Gelabert · Graduate School Of Public Health And Health Policy · R01 · FY2019 · DA
Engineering viral-specific T cells with improved function and persistence
$554,648E. John Wherry · University Of Pennsylvania · P01 · FY2025 · AI
Novel mechanism based treatment to improve tissue injury in alcoholic hepatitis
$554,644Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · AA
Understanding the underlying toxicological mechanisms of drug-hormone interactions to improve the safety profile of antiviral medications in pregnant people, developing fetuses, and neonates
$554,627Jed Noah Lampe · University Of Colorado Denver · R01 · FY2025 · AI
MAF1 Function and Metabolic Inefficiency
$554,600Ian M Willis · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · GM
Atherogenic Patheways Mediated by FOXO
$554,526Domenico Accili · Columbia University Health Sciences · P01 · FY2007 · HL
Mechanistic function of HCV NS5A targeted by the potent inhibitors
$554,525Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2022 · AI
Mechanistic function of HCV NS5A targeted by the potent inhibitors
$554,525Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2021 · AI
Mechanistic function of HCV NS5A targeted by the potent inhibitors
$554,525Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2024 · AI